IncobotulinumtoxinA Efficacy / Safety in Upper-Limb Spasticity in Pediatric Cerebral Palsy: Randomized Controlled Trial

This randomized, phase 3 study with double-blind main period (MP) and open-label extension (OLEX; NCT02002884) assessed incobotulinumtoxinA safety and efficacy for pediatric upper-limb spasticity treatment in ambulant/non-ambulant (Gross Motor Function Classification System [GMFCS] I –V) patients, with the option of combined upper- and lower-limb treatment.

Source: Pediatric Neurology - May 20, 2021 Category: Neurology Authors: Edward Dabrowski, Henry G. Chambers, Deborah Gaebler-Spira, Marta Banach, Petr Ka ňovský, Hanna Dersch, Michael Althaus, Thorin L. Geister, Florian Heinen Tags: Research Paper Source Type: research